These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1267 related items for PubMed ID: 16289096

  • 1. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
    Lawrence CP, Chow SC.
    FEBS Lett; 2005 Nov 21; 579(28):6465-72. PubMed ID: 16289096
    [Abstract] [Full Text] [Related]

  • 2. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
    Suliman A, Lam A, Datta R, Srivastava RK.
    Oncogene; 2001 Apr 19; 20(17):2122-33. PubMed ID: 11360196
    [Abstract] [Full Text] [Related]

  • 3. Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB.
    Ou D, Wang X, Metzger DL, Robbins M, Huang J, Jobin C, Chantler JK, James RF, Pozzilli P, Tingle AJ.
    Hum Immunol; 2005 Jul 19; 66(7):799-809. PubMed ID: 16112027
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis.
    Seol DW, Li J, Seol MH, Park SY, Talanian RV, Billiar TR.
    Cancer Res; 2001 Feb 01; 61(3):1138-43. PubMed ID: 11221844
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule.
    Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B, Tschopp J.
    Nat Immunol; 2000 Dec 01; 1(6):489-95. PubMed ID: 11101870
    [Abstract] [Full Text] [Related]

  • 8. Induction of apoptosis by TNF receptor 2 in a T-cell hybridoma is FADD dependent and blocked by caspase-8 inhibitors.
    Depuydt B, van Loo G, Vandenabeele P, Declercq W.
    J Cell Sci; 2005 Feb 01; 118(Pt 3):497-504. PubMed ID: 15657078
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC.
    Ramaswamy M, Efimova EV, Martinez O, Mulherkar NU, Singh SP, Prabhakar BS.
    Oncogene; 2004 Aug 12; 23(36):6083-94. PubMed ID: 15208670
    [Abstract] [Full Text] [Related]

  • 11. Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells.
    Knight MJ, Riffkin CD, Muscat AM, Ashley DM, Hawkins CJ.
    Oncogene; 2001 Sep 13; 20(41):5789-98. PubMed ID: 11593384
    [Abstract] [Full Text] [Related]

  • 12. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex.
    Izeradjene K, Douglas L, Delaney AB, Houghton JA.
    Cancer Res; 2004 Nov 01; 64(21):8036-44. PubMed ID: 15520213
    [Abstract] [Full Text] [Related]

  • 13. The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathway.
    Liu B, Fan Z.
    Oncogene; 2001 Jun 21; 20(28):3726-34. PubMed ID: 11439335
    [Abstract] [Full Text] [Related]

  • 14. Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells.
    Milner AE, Palmer DH, Hodgkin EA, Eliopoulos AG, Knox PG, Poole CJ, Kerr DJ, Young LS.
    Cell Death Differ; 2002 Mar 21; 9(3):287-300. PubMed ID: 11859411
    [Abstract] [Full Text] [Related]

  • 15. Long lasting heat shock stimulation of TRAIL-induced apoptosis in transformed T lymphocytes.
    Moulin M, Arrigo AP.
    Exp Cell Res; 2006 Jun 10; 312(10):1765-84. PubMed ID: 16584728
    [Abstract] [Full Text] [Related]

  • 16. Intracellular mediators of erucylphosphocholine-induced apoptosis.
    Jendrossek V, Müller I, Eibl H, Belka C.
    Oncogene; 2003 May 01; 22(17):2621-31. PubMed ID: 12730676
    [Abstract] [Full Text] [Related]

  • 17. Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects.
    Baader E, Toloczko A, Fuchs U, Schmid I, Beltinger C, Ehrhardt H, Debatin KM, Jeremias I.
    Cancer Res; 2005 Sep 01; 65(17):7888-95. PubMed ID: 16140959
    [Abstract] [Full Text] [Related]

  • 18. Doxorubicin-induced death in neuroblastoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells.
    Hopkins-Donaldson S, Yan P, Bourloud KB, Muhlethaler A, Bodmer JL, Gross N.
    Oncogene; 2002 Sep 05; 21(39):6132-7. PubMed ID: 12203125
    [Abstract] [Full Text] [Related]

  • 19. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).
    Chopin V, Slomianny C, Hondermarck H, Le Bourhis X.
    Exp Cell Res; 2004 Aug 15; 298(2):560-73. PubMed ID: 15265702
    [Abstract] [Full Text] [Related]

  • 20. TNF-alpha-induced apoptosis in neonatal lymphocytes: TNFRp55 expression and downstream pathways of apoptosis.
    Aggarwal S, Gollapudi S, Yel L, Gupta AS, Gupta S.
    Genes Immun; 2000 Aug 15; 1(4):271-9. PubMed ID: 11196704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 64.